Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet. The latest ACADIA Pharmaceuticals stock prices, stock quotes, news, and ACAD history to help you invest and trade smarter. Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative medicines to address the unmet medical needs in central nervous. The ACADIA Pharmaceuticals Inc stock price today is What Is the Stock Symbol for ACADIA Pharmaceuticals Inc? The stock ticker symbol for ACADIA. Our Investor Center is designed to provide you with convenient access to company information. Stock Quote. NASDAQ: ACAD. $ -.
Stock Activity ; Open: ; Day Low: ; Day High: ; 52 Wk Low: ; 52 Wk High: ACAD - ACADIA Pharmaceuticals Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred. ACADIA Pharmaceuticals Inc. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. b ; Total Shares. m. Benzinga. 8 hours ago. CEO At ACADIA Pharmaceuticals Sells $K Of Stock ; Benzinga. 8 hours ago. EVP Of ACADIA Pharmaceuticals Sold $K In Stock ; Investing. ACADIA Pharmaceuticals Inc. ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), $ ; P/E Ratio (TTM), ; Dividend Yield, N/A. The average price target is $ with a high forecast of $ and a low forecast of $ ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical. ACADIA Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today's real-time ACAD stock price. SAN DIEGO, August 06, Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the second quarter ended June 30, See the latest ACADIA Pharmaceuticals Inc stock price (ACAD:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Acadia Pharmaceuticals Inc (ACAD) Q3 Earnings Call Transcript. ACAD earnings call for the period ending November 8, Motley Fool Transcribers |. ACADIA Pharmaceuticals Inc. · · Partner Center · Your Watchlists · Recently Viewed Tickers · ACAD Overview · Key Data · Performance · Analyst Ratings. (Nasdaq: ACAD) announced today the pricing of its public offering of 4,, shares of its common stock. The public offering price of $ per share. About ACADIA Pharma (ACAD) ; EBITDA (TTM). $M ; Open. $ ; Price / earnings ratio. -1,x ; Today's range. $ - $ ; Debt / equity. x. ACADIA Pharmaceuticals Inc ACAD:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date12/22/23 · 52 Week. Acadia Pharmaceuticals Inc ; Nov, Initiated, Loop Capital, Hold, $17 ; Aug, Downgrade, Citigroup, Buy → Neutral, $19 → $ Discover real-time ACADIA Pharmaceuticals Inc. Common Stock (ACAD) stock prices, quotes, historical data, news, and Insights for informed trading and. Discover historical prices for ACAD stock on Yahoo Finance. View daily, weekly or monthly format back to when ACADIA Pharmaceuticals Inc. stock was issued. All of the shares were offered by ACADIA at a price to the public of $ per share. The gross proceeds from this offering to ACADIA were $ million, before.
(NASDAQ: ACAD) Acadia Pharmaceuticals currently has ,, outstanding shares. With Acadia Pharmaceuticals stock trading at $ per share, the total. What was ACADIA Pharmaceuticals's price range in the past 12 months? ACADIA Pharmaceuticals lowest stock price was $ and its highest was $ in the past. ACADIA Pharmaceuticals Inc ; Previous Close: ; Volume: ; 3 Month Average Trading Volume: ; Shares Out (Mil): ; Market Cap: 2, Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. (Nasdaq: ACAD) today announced the pricing of its initial public offering of 5,, shares of common stock at a price of $ per share. All of the.
Viking's obesity drug study results are 'almost flawless', says Oppenheimer's Jay Olson
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical. The last closing price for Acadia Pharmaceuticals was $ Over the last year, Acadia Pharmaceuticals shares have traded in a share price range of $ to. Market. Shares outstanding. M Market cap. $B Enterprise value. $B Valuations. Price to earnings (P/E). Price to book (P/B) · Per share.
Withdrawing From An Inherited Ira | Best Mutual Funds For Seniors